共 21 条
[4]
Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis[J] . Mattia Bianchi,Alberto Cavaliere,Davide Chiaroni,Federico Frattini,Vittorio Chiesa.Technovation . 2010 (1)
[5]
Some immediate – but negative – effects of openness on product development performance[J] . Technovation . 2010 (1)
[6]
Unravelling the process from Closed to Open Innovation: evidence from mature, asset‐intensive industries[J] . DavideChiaroni,VittorioChiesa,FedericoFrattini.R&D Management . 2010 (3)
[7]
The Open Innovation Journey: How firms dynamically implement the emerging innovation management paradigm[J] . Davide Chiaroni,Vittorio Chiesa,Federico Frattini.Technovation . 2009 (1)
[8]
Challenges of open innovation: the paradox of firm investment in open‐source software[J] . Joel West,Scott Gallagher.R&D Management . 2006 (3)
[9]
Opening up the innovation process: towards an agenda[J] . OliverGassmann.R&D Management . 2006 (3)
[10]
The role of technology in the shift towards open innovation: the case of Procter & Gamble[J] . MarkDodgson,DavidGann,AmmonSalter.R&D Management . 2006 (3)

